The Hidden Upside in Pharma and Medtech Marketing Media Spend
Marketing media remains one of the least transparent spend categories in pharma and medtech. Learn how greater transparency, structured sourcing, and cross functional collaboration help organizations gain control, unlock value, and strengthen marketi...
Pharma Procurement: Achieving the Next Efficiency Leap in Cost...
Cost excellence has become a strategic imperative in pharma. Discover how leading organizations unlock sustainable savings across direct and indirect spend, and why AI-driven changes in supplier cost structures create new procurement opportunities.
Healthcare organizations must accelerate innovation while meeting strict regulatory requirements. The right technology partners are key to balancing speed, compliance and long-term resilience.
Innovation remains non-negotiable in pharmaceutical R&D – but so does cost discipline. With longer innovation cycles, tightening budgets, and increasingly complex supplier ecosystems, traditional ways of managing R&D expenses are no longer sustainabl...
Healthcare procurement: the impact of due diligence laws
Ahead of the new EU Supply Chain Law, most companies in the healthcare sector have begun compliance efforts, though some doubt its practical implementation. A survey conducted at the end of 2023 included over 650 decision-makers from Germany and Fran...
Toward net zero: how to empower sustainability in healthcare
Companies must start reducing greenhouse gas emissions to prevent irreversible climate change damage. With the 5th highest CO2 emissions globally, the healthcare sector must lead the transition to net zero, with procurement support essential for succ...
Thomas Udesen is CPO at Bayer. In this interview, he talks to us about changes in procurement, how a Life Science company with core competencies in the areas of healthcare and agriculture can become sustainable.
